‘Digital twins’ of immune system in pregnancy identify drugs to prevent early labor, Stanford Medicine-led study finds

Top Story‘Digital twins’ of immune system in pregnancy identify drugs to prevent early labor, Stanford Medicine-led study finds

Stanford Medicine

Stanford researchers have created an AI-powered "digital twin" system to model the immune system during pregnancy, enabling the identification of drug combinations to prevent preterm labor. Using an immune system atlas, the team discovered that combining aspirin with lansoprazole delays labor significantly more effectively than aspirin alone. This is the first major pharmacological advance in preterm birth prevention in decades. A clinical trial is now underway to validate the findings.

Preterm birth is the leading cause of death for children under five globally, affecting 10% of pregnancies. This research builds on two decades of Stanford’s work in maternal immunology and positions the university as a leader in integrating AI with medical innovation.

Investment implication: This breakthrough enhances Stanford’s reputation in AI-driven healthcare research, likely attracting new funding and partnerships. For you, it highlights the accelerating role of AI in addressing complex medical challenges, with potential impacts on healthcare innovation and funding priorities.